Table 1. Clinicopathologic Data at Diagnosis.

	No ADT (n = 67)	ADT (n = 59)	p-value
PSA	6.5 (IQR 5.3–8.5)*	9.6 (IQR 6.7–15.6)	0.0003
Positive Cores	3 (IQR 2–4)*	4 (IQR 3–6)	0.01
Gleason Score (all)	7 (IQR 6–7)*	7 (IQR 7–8)	0.005
5	0	1 (1.7%)	0.003
6	18 (28)	10 (17)
7	40 (63)	28 (48)
8	4 (6.3)	6 (10)
9	2 (3.1)	14 (24)
Clinical Stage			< .0001
T1b	1(1.6)	0
T1c	23(36.5)	11(18.6)
T2a	30(47.6)	18(30.5)
T2b	5(7.9)	7(11.9)
T2c	4(6.4)	8(13.6)
T3	0	15(25.4)
Length of ADT (mo)	-	6.1 (2.9)

* Median PSA, positive cores, and Gleason Score.